ESSA Announces Filing of Amended and Restated Prospectus Supplement and an Update to Previously Announced Equity Offering

HOUSTON, TX and VANCOUVER, Jan. 2, 2018 /PRNewswire/ - ESSA Pharma Inc. (TSXV: EPI; NASDAQ: EPIX) ("ESSA" or the "Company") announces a further update to its previously announced equity offering. The Company intends to issue up to 125,000,000 common shares of the Company ("Common Shares")...